Enhancement of tumor initiation and expression of KCNMA1, MORF4L2 and ASPM genes in the adenocarcinoma of lung xenograft after vorinostat treatment
暂无分享,去创建一个
Chun-Ming Tsai | Ren-Shyan Liu | Chun-Yi Wu | Jhih-Shian Lee | Juri Gelovani | T. Chou | Chun-Ming Tsai | Kang-Ping Lin | J. Gelovani | Hsin-Ell Wang | Ren-Shyan Liu | Chun-Yi Wu | Kang-Ping Lin | Hsin-Ell Wang | Luen Hwu | Teh-Ying Chou | L. Hwu | Wei-Ying Kuo | Cheng-Han Tsai | Jhih-Shian Lee | Cheng-Han Tsai | W. Kuo | C. Tsai
[1] R A Rifkind,et al. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. , 2000, Cancer research.
[2] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[3] C. Marras,et al. Enhancer of Zeste 2 (EZH2) is up‐regulated in malignant gliomas and in glioma stem‐like cells , 2011, Neuropathology and applied neurobiology.
[4] S. Friedman,et al. CD133+ Anaplastic Thyroid Cancer Cells Initiate Tumors in Immunodeficient Mice and Are Regulated by Thyrotropin , 2009, PloS one.
[5] P. Dalerba,et al. Identification of pancreatic cancer stem cells. , 2006, Cancer research.
[6] N. Wright,et al. Side populations of gastrointestinal cancers are not enriched in stem cells , 2008, The Journal of pathology.
[7] Chia-Ying Lin,et al. Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99‐1 cells based on high aldehyde dehydrogenase activity , 2011, International journal of cancer.
[8] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[9] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[10] L. Schwartz,et al. Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Meng-chao Wu,et al. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines , 2011, BMC gastroenterology.
[12] Fazlul H. Sarkar,et al. Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins? , 2011, Cancers.
[13] Laura A. Sullivan,et al. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. , 2010, Cancer research.
[14] R. Hruban,et al. Allelotype of pancreatic adenocarcinoma using xenograft enrichment. , 1995, Cancer research.
[15] Tao Zhang,et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. , 2009, Cancer research.
[16] S. Akunuru,et al. Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity , 2012, Cell Death and Disease.
[17] Dan M. Bolser,et al. Ensembl Genomes 2013: scaling up access to genome-wide data , 2013, Nucleic Acids Res..
[18] T. Efferth,et al. Cytotoxicity, anti-angiogenic, apoptotic effects and transcript profiling of a naturally occurring naphthyl butenone, guieranone A , 2012, Cell Division.
[19] S. Chiou,et al. Overexpression of NBS1 induces epithelial–mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer , 2007, Oncogene.
[20] Sungpil Yoon,et al. Molecular Mechanism of SAHA on Regulation of Autophagic Cell Death in Tamoxifen-Resistant MCF-7 Breast Cancer Cells , 2012, International journal of medical sciences.
[21] W. Hall,et al. Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties. , 2008, Stem cells and development.
[22] Daniel Birnbaum,et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.
[23] K. Chan,et al. Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations , 2008, Molecular Cancer Research.
[24] W. McBride,et al. Radiation Resistance of Cancer Stem Cells: The 4 R's of Radiobiology Revisited , 2010, Stem cells.
[25] Wei-ru Xu,et al. Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway , 2011, Journal of experimental & clinical cancer research : CR.
[26] D. Khaitan,et al. Role of KCNMA1 gene in breast cancer invasion and metastasis to brain , 2009, BMC Cancer.
[27] S. Henderson,et al. Kaposi sarcoma herpesvirus–induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma , 2004, Nature Genetics.
[28] M. Caligiuri,et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.
[29] Feng Jiang,et al. Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer , 2009, Molecular Cancer Research.
[30] J. Visvader,et al. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.
[31] S. Steinberg,et al. Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. , 2011, Blood.
[32] Daniel H. Geschwind,et al. Cancerous stem cells can arise from pediatric brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[33] Wenjun Guo,et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds , 2008, Nature Biotechnology.
[34] Chi-Wai Wong,et al. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein , 1998, Oncogene.
[35] A. Calvo,et al. Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer , 2011, Molecular Cancer.
[36] Sharmila Shankar,et al. Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells , 2011, PloS one.
[37] Hao Wang,et al. Histone deacetylase inhibitor induction of epithelial-mesenchymal transitions via up-regulation of Snail facilitates cancer progression. , 2013, Biochimica et biophysica acta.
[38] Chi-Hung Huang,et al. Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition , 2010, Nature Cell Biology.
[39] M. Wicha,et al. Cancer stem cells: a step toward the cure. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] M. Duvic,et al. Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma , 2007, Expert opinion on investigational drugs.
[41] P. Marks,et al. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[42] R A Rifkind,et al. Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[43] Y. Marie,et al. ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target , 2010, Cancer Cell International.
[44] Mohamed H. Sayegh,et al. Identification of cells initiating human melanomas , 2008, Nature.